Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update

Brazilian guideline for the use of immunobiologicals in chronic rhinosinusitis with nasal polyps ‒ 2024 update

Introduction: Biologics targeting type 2 inflammation have revolutionized the way we treat patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). Particularly in severe and difficult-to-control cases, these drugs have provided a new reality for these patients, allowing for the effective an...

Full description

Bibliographic Details
Main Authors: Wilma T. Anselmo-Lima, Fabrizio R. Romano, Edwin Tamashiro, Renato Roithmann, Vanessa R.P. Dinarte, Otavio B. Piltcher, Marcel M. Miyake, Marco A. Fornazieri, Marcio Nakanishi, Thiago F.P. Bezerra, Ricardo L.L. Dolci, João F. Mello Jr, Marcus M. Lessa, Richard L. Voegels, Eduardo M. Kosugi, Eulalia Sakano, Fabiana C.P. Valera
Format: Article
Language:English
Published: Elsevier 2024-05-01
Series:Brazilian Journal of Otorhinolaryngology
Subjects:
Biologicals
Monoclonal antibodies
Chronic rhinosinusitis
Nasal polyp
Online Access:http://www.sciencedirect.com/science/article/pii/S1808869424000090

Internet

http://www.sciencedirect.com/science/article/pii/S1808869424000090

Similar Items